Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review.

ABSTRACT:

Background

Systematic screening for active tuberculosis (TB) is a strategy which requires the health system to seek out individuals, rather than waiting for individuals to self-present with symptoms (i.e., passive case finding). Our review aimed to summarize the current economic evidence and understand the costs and cost-effectiveness of systematic screening approaches among high-risk groups and settings.

Methods

We conducted a systematic review on economic evaluations of screening for TB disease targeting persons with clinical and/or structural risk factors, such as persons living with HIV (PLHIV) or persons experiencing homelessness. We searched three databases for studies published between January 1, 2010 and February 1, 2020. Studies were included if they reported cost a

SUBMITTER: Alsdurf H 

PROVIDER: S-EPMC8425319 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature